ABSI Absci Corp
Company Analysis
Latest News
🔴 Absci is trading 7.25% down today amid broad U.S. equity selloff
Absci is trading 7.25% down at $8.57 as U.S. equities sell off, with the Nasdaq Composite down 1.49% and the S&P 500 down 0.67%. - No new company-specific...
🔴 Absci is trading 5.18% down today after Q2 revenue missed and losses exceeded forecasts
Absci is trading 5.18% down now at $8.97 as investors continue digesting the August 11 earnings report and its disappointment. - Q2 revenue was $0.3 million...
🔴 Absci is trading 11% down in pre-market after Q2 revenue missed estimates by 70.3%
Absci is trading -10.52% now at $8.42 after August 11, 2026 earnings showed Q2 revenue of $0.3 million versus approximately $1.01 million expected and a...
🔴 Absci is trading 9.84% down in pre-market after second-quarter revenue and loss missed expectations
Absci is trading at $8.48 (-9.84%) in pre-market after its August 11, 2026 second-quarter results missed analyst expectations. • Revenue was $0.3 million...
Absci Drops 10% After Earnings — Can an AI Drug Company With Almost No Revenue Justify a $1.4 Billion Valuation?
Shares shifted sharply as Absci Corp (ABSI) fell 10.2% to $8.45 the morning after releasing second-quarter 2026 results following market close on August 11....
Absci Corporation misses second quarter 2026 expectations while extending cash runway into late 2028
Absci reported second quarter 2026 revenue of $0.3 million and a net loss per share of $0.21, missing analyst estimates as the company prioritizes clinical...
🔴 Absci is trading 10.2% down in after-hours trading following a significant second-quarter revenue miss
Absci is trading at $8.45 (-10.20%) after its second-quarter earnings release. - The company reported Q2 2026 revenue of $0.3 million, significantly below...
🟢 Absci is trading 5.77% up today ahead of August 11, 2026 second-quarter earnings
Absci is trading 5.77% up now at $9.45, as investors appear focused on its scheduled August 11, 2026, second-quarter earnings and business update. - Analysts...
Absci Corp Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Absci Corp is projected to report a consensus revenue of $0.90 million and an EPS of -$0.18 for the second quarter of 2026, with its stock trading at $8.93...
🟢 Absci is trading 5% up today + biotech sector momentum
Absci is trading 5.06% up now at $8.72, primarily amid biotech-sector momentum. - No new company-specific announcement was identified for August 7, 2026. -...
🟢 Absci is trading 5.2% up today extending its momentum rally amid a risk-on market
Absci is trading 5.2% up today at $8.34, extending a sharp rally that began in late June following positive data for its ABS-201 hair loss therapy. • The...
🟢 Absci is trading 7.3% up today as momentum extends in a risk-on market
Absci is trading 7.3% up today at $8.51 in pre-market, extending its strong momentum from late July. • The move is driven by a broadly risk-on tone in U.S....
🟢 Absci is trading 6.7% up today as momentum continues without a fresh catalyst
Absci is trading at $8.30 (+6.7%) in pre-market, extending its strong gains from July 30 and July 31 despite a lack of fresh company-specific news. • The move...
🟢 Absci is trading 10% up today amid a risk-on rally in tech and biotech sectors
Absci is trading 10% up at $7.59 as the stock benefits from a strong risk-on rally across the tech and biotech sectors. • The move follows a broader Nasdaq...
🟢 Absci is trading 5.8% up today amid a broader market rally and biotech sector strength
Absci is trading at $7.30 (+5.80%) following a strong market open, though no company-specific announcements were released to explain the move. • The stock is...
🔴 Absci is trading 5.8% down today as it pulls back from a recent sector-driven rebound
Absci is trading 5.8% down at $7.12 today, giving back a portion of its recent gains fueled by a broader biotech sector rally. • The move appears to be a...
🟢 Absci is trading 7% up today as it rebounds amid a broader market rally
Absci is trading 7% higher at $8.07, rebounding from recent dilution-related weakness as broader U.S. markets show strength. • The move appears aligned with a...
🔴 Absci is trading 5.2% down today as it extends a pullback from its recent parabolic rally
Absci is trading at $7.65 (down 5.2%) as it extends a pullback following a parabolic rally and a sharp drop in last Thursday’s extended session. • The recent...
🔴 Absci is trading 5.2% down today as it extends a sharp selloff amid broader biotech weakness
Absci is trading 5.2% down at $7.80 as it extends a sharp selloff from the July 16 session amid broader biotech weakness. • The move follows a 16.5% drop on...
🔴 Absci is trading 10.2% down
Absci is trading at $8.77, down 10.2% from a comparison close of $9.76 during regular trading. This is a price-action follow-up, so a separate catalyst may not...